Tokyo Tape
Sign in

Noiruimunbaiotekku

4893.TTSE GROWTHPharmaceutical
Filed as Noile-Immune Biotech Inc. (2023-08–2026-08)
Major holders (5%+) · 1
HolderStakeChangeFiled
TSURUKAME CO., LTD16.75%-1.27pp2024-07-31

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 3
Hidenobu Ishizaki4.55%2024-05-24
Hiroko Ogihara2.31%2024-07-31
APRICOT CO., LTD.1.57%2024-07-31
Ownership history · 16
FiledHolderRatioChangePurpose
2024-07-31AmendedAPRICOT CO., LTD.2024-07-31 · amended1.57%no changePure investment
2024-07-31AmendedHiroko Ogihara2024-07-31 · amended2.31%no changePure investment
2024-07-31AmendedTSURUKAME CO., LTD2024-07-31 · amended16.75%-1.27ppPure investment
2024-07-26AmendedAPRICOT CO., LTD.2024-07-26 · amended1.57%no changePure investment
2024-07-26AmendedHiroko Ogihara2024-07-26 · amended2.31%no changePure investment
2024-07-26AmendedTSURUKAME CO., LTD2024-07-26 · amended18.02%-3.24ppPure investment
2024-06-21AmendedAPRICOT CO., LTD.2024-06-21 · amended1.57%-1.21ppPure investment
2024-06-21AmendedHiroko Ogihara2024-06-21 · amended2.31%no changePure investment
2024-06-21AmendedTSURUKAME CO., LTD2024-06-21 · amended21.26%-0.47ppPure investment
2024-05-24AmendedHidenobu Ishizaki2024-05-24 · amended4.55%newStable shareholder; Long-term holding
2024-03-06AmendedHiroko Ogihara2024-03-06 · amended2.31%no changePure investment
2024-03-06AmendedAPRICOT CO., LTD.2024-03-06 · amended2.78%no changePure investment
2024-03-06AmendedTSURUKAME CO., LTD2024-03-06 · amended21.73%-1.08ppPure investment
2024-02-15AmendedHiroko Ogihara2024-02-15 · amended2.31%newPure investment
2024-02-15AmendedAPRICOT CO., LTD.2024-02-15 · amended2.78%newPure investment
2024-02-15AmendedTSURUKAME CO., LTD2024-02-15 · amended22.81%newPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.